Filing Details

Accession Number:
0001728117-22-000061
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-15 16:23:00
Reporting Period:
2022-07-15
Accepted Time:
2022-07-15 16:23:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS Pharmaceutical Preparations (2834) 475461709
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740847 Bryan Giraudo 3013 Science Park Road
San Diego CA 92121
Coo/Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-15 13,869 $7.21 20,990 No 4 P Indirect By family trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By family trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,167 Direct
Footnotes
  1. The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,722 shares, with the Reporting Person's sale of 10,722 shares of common stock at a price of $8.915 per share on March 23, 2022. The Reporting Person paid to the Issuer $18,281.01, representing the full amount of the profit realized in connection with the short-swing transaction.